糖心vlog

In the Original Investigation titled 鈥淒rugs for Primary Prevention of Atherosclerotic Cardiovascular Disease: An Overview of Systematic Reviews,鈥� published in the June issue of JAMA Cardiology,¹ a conversion factor for a 1-mmol/L reduction of low-density lipoprotein (LDL) cholesterol in the Table and text was erroneously listed as 40.6 mg/dL instead of 38.7 mg/dL. In the first column of the Table, the third entry under Statins should have read, 鈥淢ajor vascular events per 38.7 mg/dL of LDL cholesterol level reduction.鈥� In the Statins subsection of the Results section in the text, the last sentence of the Efficacy and Cardiovascular Benefits subsection should have read, 鈥淭reatment effects standardized per 38.7鈥搈g/dL reduction in levels of low-density lipoprotein cholesterol were also reported by the Cholesterol Treatment Trialists鈥� Collaboration³⁸ for all-cause mortality (RR, 0.91; 95% CI, 0.85-0.97) and major vascular events (RR, 0.75; 95% CI, 0.70-0.80).鈥� This article was corrected online.